Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Supports exercise to enhance NO bioavailability in CVD; leaves open optimal protocols and clinical outcome trials.
Bronwyn A. Kingwell (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: